Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular Pathogenesis of Liver Cancer.

Literature DB >> 28718003

Molecular Pathogenesis of Liver Cancer.

Mehmet Ozturk¹, Tugce Batur², Umut Ekin², Aybike Erdogan², Evin İscan², Umur Keles², Ozden Oz², Cigdem Ozen².

Abstract

Entities: Disease

Year: 2017 PMID： 28718003 DOI： 10.1007/s12029-017-9957-2

Source DB: PubMed Journal: J Gastrointest Cancer

× No keyword cloud information.

28 in total

1. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors: B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal: Proc Natl Acad Sci U S A Date: 1990-03 Impact factor: 11.205

2. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.

Authors: Xiaoli Liu; Guojun Wu; Yuan Shan; Christian Hartmann; Andreas von Deimling; Mingzhao Xing
Journal: Cell Cycle Date: 2013-04-19 Impact factor: 4.534

3. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Authors: Jean Charles Nault; Julien Calderaro; Luca Di Tommaso; Charles Balabaud; Elie Serge Zafrani; Paulette Bioulac-Sage; Massimo Roncalli; Jessica Zucman-Rossi
Journal: Hepatology Date: 2014-10-27 Impact factor: 17.425

Review 4. Clinical implications of DNA methylation in hepatocellular carcinoma.

Authors: Eric L Sceusi; David S Loose; Curtis J Wray
Journal: HPB (Oxford) Date: 2011-03-29 Impact factor: 3.647

5. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.

Authors: Dilek Cevik; Gokhan Yildiz; Mehmet Ozturk
Journal: World J Gastroenterol Date: 2015-01-07 Impact factor: 5.742

Review 6. Hepatocellular carcinoma.

Authors: Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal: Lancet Date: 2012-02-20 Impact factor: 79.321

Review 7. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.

Authors: Marie Annick Buendia
Journal: Med Pediatr Oncol Date: 2002-11

8. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.

Authors: Julja Burchard; Chunsheng Zhang; Angela M Liu; Ronnie T P Poon; Nikki P Y Lee; Kwong-Fai Wong; Pak C Sham; Brian Y Lam; Mark D Ferguson; George Tokiwa; Ryan Smith; Brendan Leeson; Rebecca Beard; John R Lamb; Lee Lim; Mao Mao; Hongyue Dai; John M Luk
Journal: Mol Syst Biol Date: 2010-08-24 Impact factor: 11.429

Molecular Pathogenesis of Liver Cancer.

1. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

2. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.

3. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Review 4. Clinical implications of DNA methylation in hepatocellular carcinoma.

5. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.

Review 6. Hepatocellular carcinoma.

Review 7. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.

8. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.

9. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Review 10. Genetics and epigenetics of liver cancer.

Review 1. Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

2. SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway.